Therapeutic Advances in Drug Safety

Papers
(The H4-Index of Therapeutic Advances in Drug Safety is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS)28
Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis27
Impact of different doses of esketamine on the incidence of hypotension in propofol-based sedation for colonoscopy: a randomized controlled trial23
Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system15
Definition of self-medication: a scoping review14
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study11
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge11
The 7th European Pharmacovigilance Congress: speaker abstracts10
Determinants of COVID-19 vaccine-induced myocarditis10
Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis10
Drug interactions in patients with alcohol use disorder: results from a real-world study on an addiction-specific ward10
0.038506984710693